Zero100 Announces New Advisory Board Member: Karin Shanahan, EVP of Global Product Development and Supply at Bristol Myers Squibb

• Zero100 is a membership-based research and intelligence organization convening leaders to power growth, resilience, and sustainability through digital supply chain transformation.
• The Zero100 Advisory Board is a hand-picked coalition of the world’s most influential CEOs, Chief Operations and Supply Chain Officers working to accelerate progress on this mission.

---

LONDON, Nov 20, 2024 – Zero100, a leading supply chain intelligence firm, has today announced that Karin Shanahan, Executive Vice President, Global Product Development and Supply (GPS) at Bristol Myers Squibb (BMS), has been appointed to the Zero100 Advisory Board.

With over 25 years in biopharma, Karin brings unparalleled expertise in end-to-end supply chain strategy, quality management, and operational excellence. Known for her forward-thinking approach, Karin’s contributions have consistently driven high-impact change across global supply networks.

Speaking of the appointment, Olly Sloboda, Chief Executive Officer of Zero100, said:

We are honoured to welcome Karin to our Advisory Board. We’re rapidly growing representation from global pharma and healthcare leaders within Zero100, and Karin’s deep understanding of biopharma supply chains and unwavering commitment to excellence and innovation align perfectly with Zero100’s mission. Karin’s unique insight and leadership will be invaluable as we pioneer advancements in digital supply chain resilience and sustainability.”

Commenting on her new role, Karin stated:

I am excited to join the Zero100 Advisory Board at a time when supply chain transformation has never been more critical. Working alongside the dynamic leaders on this Board offers a unique opportunity to help Zero100 shape the future of resilient, impactful supply chains.”

In her role at BMS, Karin oversees global product development, global supply chain, global quality, global technical services, strategy and business excellence, and global manufacturing operations in biologics, small molecule and cell therapy development—all to help fulfil BMS’ vision of transforming patients’ lives through science. Through Karin’s focus on operational excellence, the GPS function has been instrumental in delivering high-quality, innovative medicines to over 80 markets globally.

Her impressive career spans global leadership roles at prominent companies, including Becton-Dickinson, Catalent Pharmaceuticals, Teva Pharmaceuticals, and Merck. Known for her commitment to cross-functional collaboration, seeking out diverse perspectives to drive scientific breakthroughs and transformative results, she has continually redefined industry standards in quality and efficiency, making her a respected figure in global supply chain strategy.

About Zero100

The world’s most influential and forward-thinking chief operations and supply chain officers partner with Zero100, a membership-based research and intelligence organization, to accelerate progress on digital supply chain transformation.

Zero100’s approach combines unique IP-led research and data, intimate executive-level events, personalized guidance, and access to an extensive community of influential thinkers and voices from within, and beyond, supply chain.

The company is headquartered in London, UK, with offices in New York, USA.

Zero100 members include Walmart, Google, Unilever, Volvo Cars, PUMA, Bayer, The Estée Lauder Companies, PepsiCo, Pfizer, Colgate-Palmolive, Kimberly-Clark, Ecolab, Under Armour, Alibaba, and more. 

To find out more, including a full list of our Advisory Board members, visit https://zero100.com/about-us/.